68Ga-BOT5035

N/A

Report date: 2025/11/20 16:03:46

NME

Base Information

Drug Name68Ga-BOT5035

Drug Alias Name68Ga-BOT5035

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionPositron-emission tomography enhancersPlatelet-derived growth factor receptor beta modulators

TargetsPlatelet-derived growth factor receptor beta

Therapy Area/IndicationsHeart FailureAtrial Fibrillation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBiorion Technologies Cortalix BV

China Registration ClassN/A

Develop Information

Active CompaniesCortalix BV Biorion Technologies

Inactive CompaniesN/A

Active IndicationsHeart FailureAtrial Fibrillation

Inactive IndicationsN/A

Other Information

ATC CodeN/A